nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—SLCO4C1—Dextrothyroxine—hypothyroidism	0.097	0.118	CbGbCtD
Methotrexate—SLCO4C1—Levothyroxine—hypothyroidism	0.0735	0.0896	CbGbCtD
Methotrexate—SLCO4C1—Liothyronine—hypothyroidism	0.0735	0.0896	CbGbCtD
Methotrexate—SLCO4C1—Liotrix—hypothyroidism	0.0718	0.0874	CbGbCtD
Methotrexate—SLCO1C1—Dextrothyroxine—hypothyroidism	0.0681	0.083	CbGbCtD
Methotrexate—SLCO1C1—Liothyronine—hypothyroidism	0.0516	0.0629	CbGbCtD
Methotrexate—SLCO1C1—Levothyroxine—hypothyroidism	0.0516	0.0629	CbGbCtD
Methotrexate—SLCO1C1—Liotrix—hypothyroidism	0.0504	0.0614	CbGbCtD
Methotrexate—SLCO1B3—Levothyroxine—hypothyroidism	0.0288	0.0351	CbGbCtD
Methotrexate—SLCO1B3—Liothyronine—hypothyroidism	0.0288	0.0351	CbGbCtD
Methotrexate—SLCO1B3—Liotrix—hypothyroidism	0.0281	0.0343	CbGbCtD
Methotrexate—SLCO1B1—Dextrothyroxine—hypothyroidism	0.0222	0.027	CbGbCtD
Methotrexate—SLCO1A2—Liothyronine—hypothyroidism	0.0178	0.0217	CbGbCtD
Methotrexate—SLCO1A2—Levothyroxine—hypothyroidism	0.0178	0.0217	CbGbCtD
Methotrexate—SLCO1A2—Liotrix—hypothyroidism	0.0174	0.0212	CbGbCtD
Methotrexate—SLCO1B1—Levothyroxine—hypothyroidism	0.0168	0.0205	CbGbCtD
Methotrexate—SLCO1B1—Liothyronine—hypothyroidism	0.0168	0.0205	CbGbCtD
Methotrexate—SLCO1B1—Liotrix—hypothyroidism	0.0164	0.02	CbGbCtD
Methotrexate—SLC22A8—Liothyronine—hypothyroidism	0.0155	0.0189	CbGbCtD
Methotrexate—SLC22A8—Liotrix—hypothyroidism	0.0151	0.0184	CbGbCtD
Methotrexate—ALB—Liothyronine—hypothyroidism	0.0092	0.0112	CbGbCtD
Methotrexate—ALB—Levothyroxine—hypothyroidism	0.0092	0.0112	CbGbCtD
Methotrexate—ALB—Liotrix—hypothyroidism	0.00898	0.0109	CbGbCtD
Methotrexate—ABCB1—Levothyroxine—hypothyroidism	0.00481	0.00586	CbGbCtD
Methotrexate—ABCB1—Liothyronine—hypothyroidism	0.00481	0.00586	CbGbCtD
Methotrexate—ABCB1—Liotrix—hypothyroidism	0.0047	0.00572	CbGbCtD
Methotrexate—Infertility—Levothyroxine—hypothyroidism	0.00446	0.0777	CcSEcCtD
Methotrexate—Infertility—Dextrothyroxine—hypothyroidism	0.00446	0.0777	CcSEcCtD
Methotrexate—Infertility—Liotrix—hypothyroidism	0.00328	0.0572	CcSEcCtD
Methotrexate—SLC19A1—tongue—hypothyroidism	0.00292	0.0342	CbGeAlD
Methotrexate—Intestinal perforation—Liotrix—hypothyroidism	0.00216	0.0378	CcSEcCtD
Methotrexate—SLC22A8—urine—hypothyroidism	0.00127	0.0149	CbGeAlD
Methotrexate—Cyanosis—Liotrix—hypothyroidism	0.00121	0.0211	CcSEcCtD
Methotrexate—SLC19A1—heart—hypothyroidism	0.00111	0.013	CbGeAlD
Methotrexate—Necrosis—Liotrix—hypothyroidism	0.00109	0.019	CcSEcCtD
Methotrexate—Abscess—Liotrix—hypothyroidism	0.00108	0.0189	CcSEcCtD
Methotrexate—Coma—Levothyroxine—hypothyroidism	0.00106	0.0185	CcSEcCtD
Methotrexate—Coma—Dextrothyroxine—hypothyroidism	0.00106	0.0185	CcSEcCtD
Methotrexate—FOLR1—pituitary gland—hypothyroidism	0.00106	0.0124	CbGeAlD
Methotrexate—ABCC11—gonad—hypothyroidism	0.00104	0.0122	CbGeAlD
Methotrexate—Extravasation—Liotrix—hypothyroidism	0.000981	0.0171	CcSEcCtD
Methotrexate—SLC19A1—gonad—hypothyroidism	0.000949	0.0111	CbGeAlD
Methotrexate—FOLR1—blood—hypothyroidism	0.000943	0.0111	CbGeAlD
Methotrexate—Oliguria—Liotrix—hypothyroidism	0.000929	0.0162	CcSEcCtD
Methotrexate—FOLR1—thyroid gland—hypothyroidism	0.00091	0.0107	CbGeAlD
Methotrexate—Ulcer—Liotrix—hypothyroidism	0.000905	0.0158	CcSEcCtD
Methotrexate—SLC46A1—adrenal cortex—hypothyroidism	0.000883	0.0103	CbGeAlD
Methotrexate—FOLR1—female gonad—hypothyroidism	0.00088	0.0103	CbGeAlD
Methotrexate—ABCC11—female gonad—hypothyroidism	0.000843	0.00988	CbGeAlD
Methotrexate—GGH—heart—hypothyroidism	0.00084	0.00984	CbGeAlD
Methotrexate—SLC19A1—adrenal gland—hypothyroidism	0.000827	0.00969	CbGeAlD
Methotrexate—SLC19A1—blood—hypothyroidism	0.000827	0.00969	CbGeAlD
Methotrexate—Irritability—Levothyroxine—hypothyroidism	0.000806	0.0141	CcSEcCtD
Methotrexate—Irritability—Dextrothyroxine—hypothyroidism	0.000806	0.0141	CcSEcCtD
Methotrexate—Mood swings—Levothyroxine—hypothyroidism	0.0008	0.014	CcSEcCtD
Methotrexate—Mood swings—Dextrothyroxine—hypothyroidism	0.0008	0.014	CcSEcCtD
Methotrexate—SLC19A1—thyroid gland—hypothyroidism	0.000798	0.00935	CbGeAlD
Methotrexate—Hypotension—Liothyronine—hypothyroidism	0.00079	0.0138	CcSEcCtD
Methotrexate—Coma—Liotrix—hypothyroidism	0.000782	0.0136	CcSEcCtD
Methotrexate—FPGS—adrenal cortex—hypothyroidism	0.000764	0.00895	CbGeAlD
Methotrexate—ABCC11—testis—hypothyroidism	0.000748	0.00876	CbGeAlD
Methotrexate—Sepsis—Liotrix—hypothyroidism	0.000743	0.013	CcSEcCtD
Methotrexate—FPGS—heart—hypothyroidism	0.000738	0.00865	CbGeAlD
Methotrexate—FOLR1—cerebellum—hypothyroidism	0.000721	0.00844	CbGeAlD
Methotrexate—GGH—gonad—hypothyroidism	0.000719	0.00843	CbGeAlD
Methotrexate—ATIC—heart—hypothyroidism	0.000714	0.00837	CbGeAlD
Methotrexate—SLC46A1—pituitary gland—hypothyroidism	0.000713	0.00836	CbGeAlD
Methotrexate—ABCC11—liver—hypothyroidism	0.000707	0.00829	CbGeAlD
Methotrexate—GGH—pituitary gland—hypothyroidism	0.000702	0.00822	CbGeAlD
Methotrexate—SLC19A1—testis—hypothyroidism	0.000684	0.00802	CbGeAlD
Methotrexate—ATIC—cardiovascular system—hypothyroidism	0.000674	0.0079	CbGeAlD
Methotrexate—Renal failure acute—Liotrix—hypothyroidism	0.000673	0.0117	CcSEcCtD
Methotrexate—Body temperature increased—Liothyronine—hypothyroidism	0.000668	0.0117	CcSEcCtD
Methotrexate—SLC19A1—liver—hypothyroidism	0.000647	0.00758	CbGeAlD
Methotrexate—SLC46A1—adrenal gland—hypothyroidism	0.000637	0.00747	CbGeAlD
Methotrexate—Cerebrovascular accident—Liotrix—hypothyroidism	0.000634	0.0111	CcSEcCtD
Methotrexate—SLC19A1—cerebellum—hypothyroidism	0.000632	0.0074	CbGeAlD
Methotrexate—GGH—adrenal gland—hypothyroidism	0.000627	0.00735	CbGeAlD
Methotrexate—GGH—blood—hypothyroidism	0.000627	0.00734	CbGeAlD
Methotrexate—Sweating—Dextrothyroxine—hypothyroidism	0.000624	0.0109	CcSEcCtD
Methotrexate—Sweating—Levothyroxine—hypothyroidism	0.000624	0.0109	CcSEcCtD
Methotrexate—FPGS—pituitary gland—hypothyroidism	0.000617	0.00723	CbGeAlD
Methotrexate—SLC46A1—thyroid gland—hypothyroidism	0.000615	0.00721	CbGeAlD
Methotrexate—ATIC—gonad—hypothyroidism	0.000612	0.00717	CbGeAlD
Methotrexate—GGH—thyroid gland—hypothyroidism	0.000605	0.00709	CbGeAlD
Methotrexate—SLCO1B3—pituitary gland—hypothyroidism	0.000605	0.00709	CbGeAlD
Methotrexate—SLC46A1—female gonad—hypothyroidism	0.000594	0.00696	CbGeAlD
Methotrexate—Irritability—Liotrix—hypothyroidism	0.000593	0.0103	CcSEcCtD
Methotrexate—Mood swings—Liotrix—hypothyroidism	0.000588	0.0103	CcSEcCtD
Methotrexate—GGH—female gonad—hypothyroidism	0.000585	0.00685	CbGeAlD
Methotrexate—SLCO4C1—blood—hypothyroidism	0.000556	0.00651	CbGeAlD
Methotrexate—FPGS—adrenal gland—hypothyroidism	0.000551	0.00646	CbGeAlD
Methotrexate—FPGS—blood—hypothyroidism	0.000551	0.00646	CbGeAlD
Methotrexate—ATIC—adrenal gland—hypothyroidism	0.000533	0.00625	CbGeAlD
Methotrexate—ATIC—blood—hypothyroidism	0.000533	0.00625	CbGeAlD
Methotrexate—FPGS—thyroid gland—hypothyroidism	0.000532	0.00623	CbGeAlD
Methotrexate—MTHFR—heart—hypothyroidism	0.000531	0.00622	CbGeAlD
Methotrexate—SLC46A1—testis—hypothyroidism	0.000527	0.00618	CbGeAlD
Methotrexate—SLCO3A1—heart—hypothyroidism	0.000522	0.00612	CbGeAlD
Methotrexate—GGH—testis—hypothyroidism	0.000519	0.00608	CbGeAlD
Methotrexate—Alopecia—Dextrothyroxine—hypothyroidism	0.000516	0.009	CcSEcCtD
Methotrexate—Alopecia—Levothyroxine—hypothyroidism	0.000516	0.009	CcSEcCtD
Methotrexate—ATIC—thyroid gland—hypothyroidism	0.000514	0.00603	CbGeAlD
Methotrexate—FPGS—female gonad—hypothyroidism	0.000514	0.00602	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—hypothyroidism	0.000501	0.00587	CbGeAlD
Methotrexate—SLC46A1—liver—hypothyroidism	0.000498	0.00584	CbGeAlD
Methotrexate—ATIC—female gonad—hypothyroidism	0.000497	0.00582	CbGeAlD
Methotrexate—SLCO1C1—pituitary gland—hypothyroidism	0.000496	0.00581	CbGeAlD
Methotrexate—DHFR—adrenal cortex—hypothyroidism	0.000496	0.00581	CbGeAlD
Methotrexate—GGH—liver—hypothyroidism	0.00049	0.00574	CbGeAlD
Methotrexate—SLC46A1—cerebellum—hypothyroidism	0.000487	0.0057	CbGeAlD
Methotrexate—DHFR—heart—hypothyroidism	0.00048	0.00562	CbGeAlD
Methotrexate—GGH—cerebellum—hypothyroidism	0.000479	0.00561	CbGeAlD
Methotrexate—PGD—adrenal cortex—hypothyroidism	0.000477	0.00559	CbGeAlD
Methotrexate—Renal failure—Liotrix—hypothyroidism	0.000471	0.00821	CcSEcCtD
Methotrexate—PGD—heart—hypothyroidism	0.000461	0.0054	CbGeAlD
Methotrexate—Sweating—Liotrix—hypothyroidism	0.000459	0.008	CcSEcCtD
Methotrexate—FPGS—testis—hypothyroidism	0.000456	0.00534	CbGeAlD
Methotrexate—DHFR—cardiovascular system—hypothyroidism	0.000453	0.0053	CbGeAlD
Methotrexate—SLCO3A1—gonad—hypothyroidism	0.000447	0.00524	CbGeAlD
Methotrexate—ATIC—testis—hypothyroidism	0.000441	0.00517	CbGeAlD
Methotrexate—Convulsion—Dextrothyroxine—hypothyroidism	0.000441	0.00768	CcSEcCtD
Methotrexate—Convulsion—Levothyroxine—hypothyroidism	0.000441	0.00768	CcSEcCtD
Methotrexate—SLCO3A1—pituitary gland—hypothyroidism	0.000436	0.00511	CbGeAlD
Methotrexate—PGD—cardiovascular system—hypothyroidism	0.000435	0.0051	CbGeAlD
Methotrexate—SLCO4C1—liver—hypothyroidism	0.000435	0.00509	CbGeAlD
Methotrexate—Arthralgia—Dextrothyroxine—hypothyroidism	0.000433	0.00755	CcSEcCtD
Methotrexate—Arthralgia—Levothyroxine—hypothyroidism	0.000433	0.00755	CcSEcCtD
Methotrexate—FPGS—liver—hypothyroidism	0.000431	0.00505	CbGeAlD
Methotrexate—SLC16A1—heart—hypothyroidism	0.00043	0.00504	CbGeAlD
Methotrexate—SLCO1C1—thyroid gland—hypothyroidism	0.000428	0.00501	CbGeAlD
Methotrexate—SLCO1B3—liver—hypothyroidism	0.000422	0.00495	CbGeAlD
Methotrexate—FPGS—cerebellum—hypothyroidism	0.000421	0.00493	CbGeAlD
Methotrexate—AOX1—adrenal cortex—hypothyroidism	0.00042	0.00492	CbGeAlD
Methotrexate—Confusional state—Dextrothyroxine—hypothyroidism	0.000419	0.0073	CcSEcCtD
Methotrexate—Confusional state—Levothyroxine—hypothyroidism	0.000419	0.0073	CcSEcCtD
Methotrexate—ATIC—liver—hypothyroidism	0.000417	0.00488	CbGeAlD
Methotrexate—TYMS—gonad—hypothyroidism	0.000415	0.00486	CbGeAlD
Methotrexate—ABCC3—adrenal cortex—hypothyroidism	0.000411	0.00481	CbGeAlD
Methotrexate—DHFR—gonad—hypothyroidism	0.000411	0.00481	CbGeAlD
Methotrexate—ABCC10—adrenal cortex—hypothyroidism	0.000409	0.00479	CbGeAlD
Methotrexate—ATIC—cerebellum—hypothyroidism	0.000407	0.00477	CbGeAlD
Methotrexate—AOX1—heart—hypothyroidism	0.000406	0.00476	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—hypothyroidism	0.000406	0.00476	CbGeAlD
Methotrexate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000401	0.007	CcSEcCtD
Methotrexate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000401	0.007	CcSEcCtD
Methotrexate—DHFR—pituitary gland—hypothyroidism	0.000401	0.0047	CbGeAlD
Methotrexate—MTHFR—adrenal gland—hypothyroidism	0.000396	0.00464	CbGeAlD
Methotrexate—MTHFR—blood—hypothyroidism	0.000396	0.00464	CbGeAlD
Methotrexate—ABCC10—heart—hypothyroidism	0.000395	0.00463	CbGeAlD
Methotrexate—PGD—gonad—hypothyroidism	0.000395	0.00463	CbGeAlD
Methotrexate—SLCO3A1—adrenal gland—hypothyroidism	0.00039	0.00457	CbGeAlD
Methotrexate—SLCO3A1—blood—hypothyroidism	0.00039	0.00457	CbGeAlD
Methotrexate—PGD—pituitary gland—hypothyroidism	0.000385	0.00451	CbGeAlD
Methotrexate—MTHFR—thyroid gland—hypothyroidism	0.000382	0.00448	CbGeAlD
Methotrexate—Alopecia—Liotrix—hypothyroidism	0.00038	0.00662	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000378	0.0066	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000378	0.0066	CcSEcCtD
Methotrexate—SLCO3A1—thyroid gland—hypothyroidism	0.000376	0.00441	CbGeAlD
Methotrexate—Insomnia—Levothyroxine—hypothyroidism	0.000375	0.00655	CcSEcCtD
Methotrexate—Insomnia—Dextrothyroxine—hypothyroidism	0.000375	0.00655	CcSEcCtD
Methotrexate—Dyspnoea—Levothyroxine—hypothyroidism	0.00037	0.00645	CcSEcCtD
Methotrexate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00037	0.00645	CcSEcCtD
Methotrexate—MTHFR—female gonad—hypothyroidism	0.000369	0.00433	CbGeAlD
Methotrexate—SLC16A1—gonad—hypothyroidism	0.000369	0.00432	CbGeAlD
Methotrexate—SLCO1C1—testis—hypothyroidism	0.000367	0.00429	CbGeAlD
Methotrexate—Dysgeusia—Liotrix—hypothyroidism	0.000366	0.00639	CcSEcCtD
Methotrexate—SLCO3A1—female gonad—hypothyroidism	0.000364	0.00426	CbGeAlD
Methotrexate—TYMS—adrenal gland—hypothyroidism	0.000362	0.00424	CbGeAlD
Methotrexate—TYMS—blood—hypothyroidism	0.000361	0.00424	CbGeAlD
Methotrexate—SLC16A1—pituitary gland—hypothyroidism	0.00036	0.00421	CbGeAlD
Methotrexate—DHFR—adrenal gland—hypothyroidism	0.000358	0.00419	CbGeAlD
Methotrexate—DHFR—blood—hypothyroidism	0.000358	0.00419	CbGeAlD
Methotrexate—Fatigue—Levothyroxine—hypothyroidism	0.000358	0.00624	CcSEcCtD
Methotrexate—Fatigue—Dextrothyroxine—hypothyroidism	0.000358	0.00624	CcSEcCtD
Methotrexate—Vision blurred—Liotrix—hypothyroidism	0.000353	0.00615	CcSEcCtD
Methotrexate—TYMS—thyroid gland—hypothyroidism	0.000349	0.00409	CbGeAlD
Methotrexate—AOX1—gonad—hypothyroidism	0.000348	0.00408	CbGeAlD
Methotrexate—SLC22A7—testis—hypothyroidism	0.000347	0.00407	CbGeAlD
Methotrexate—DHFR—thyroid gland—hypothyroidism	0.000345	0.00405	CbGeAlD
Methotrexate—PGD—adrenal gland—hypothyroidism	0.000344	0.00403	CbGeAlD
Methotrexate—PGD—blood—hypothyroidism	0.000344	0.00403	CbGeAlD
Methotrexate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000342	0.00597	CcSEcCtD
Methotrexate—Feeling abnormal—Levothyroxine—hypothyroidism	0.000342	0.00597	CcSEcCtD
Methotrexate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000339	0.00592	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000339	0.00592	CcSEcCtD
Methotrexate—AOX1—pituitary gland—hypothyroidism	0.000339	0.00398	CbGeAlD
Methotrexate—ALB—heart—hypothyroidism	0.000339	0.00397	CbGeAlD
Methotrexate—ABCC10—gonad—hypothyroidism	0.000339	0.00397	CbGeAlD
Methotrexate—TYMS—female gonad—hypothyroidism	0.000337	0.00395	CbGeAlD
Methotrexate—SLC22A11—liver—hypothyroidism	0.000337	0.00394	CbGeAlD
Methotrexate—DHFR—female gonad—hypothyroidism	0.000334	0.00391	CbGeAlD
Methotrexate—PGD—thyroid gland—hypothyroidism	0.000332	0.00389	CbGeAlD
Methotrexate—ABCC10—pituitary gland—hypothyroidism	0.00033	0.00387	CbGeAlD
Methotrexate—Urticaria—Levothyroxine—hypothyroidism	0.00033	0.00575	CcSEcCtD
Methotrexate—Urticaria—Dextrothyroxine—hypothyroidism	0.00033	0.00575	CcSEcCtD
Methotrexate—SLC22A7—liver—hypothyroidism	0.000329	0.00385	CbGeAlD
Methotrexate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000328	0.00572	CcSEcCtD
Methotrexate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000328	0.00572	CcSEcCtD
Methotrexate—Abdominal pain—Levothyroxine—hypothyroidism	0.000328	0.00572	CcSEcCtD
Methotrexate—Body temperature increased—Levothyroxine—hypothyroidism	0.000328	0.00572	CcSEcCtD
Methotrexate—ABCC4—heart—hypothyroidism	0.000328	0.00384	CbGeAlD
Methotrexate—MTHFR—testis—hypothyroidism	0.000328	0.00384	CbGeAlD
Methotrexate—Convulsion—Liotrix—hypothyroidism	0.000324	0.00565	CcSEcCtD
Methotrexate—SLCO3A1—testis—hypothyroidism	0.000322	0.00378	CbGeAlD
Methotrexate—SLC16A1—adrenal gland—hypothyroidism	0.000321	0.00376	CbGeAlD
Methotrexate—PGD—female gonad—hypothyroidism	0.000321	0.00376	CbGeAlD
Methotrexate—Chest pain—Liotrix—hypothyroidism	0.000318	0.00555	CcSEcCtD
Methotrexate—Arthralgia—Liotrix—hypothyroidism	0.000318	0.00555	CcSEcCtD
Methotrexate—SLCO1B1—blood—hypothyroidism	0.000312	0.00366	CbGeAlD
Methotrexate—SLC16A1—thyroid gland—hypothyroidism	0.00031	0.00363	CbGeAlD
Methotrexate—MTHFR—liver—hypothyroidism	0.00031	0.00363	CbGeAlD
Methotrexate—Confusional state—Liotrix—hypothyroidism	0.000308	0.00537	CcSEcCtD
Methotrexate—Anaphylactic shock—Liotrix—hypothyroidism	0.000305	0.00532	CcSEcCtD
Methotrexate—SLCO3A1—liver—hypothyroidism	0.000305	0.00357	CbGeAlD
Methotrexate—Infection—Liotrix—hypothyroidism	0.000303	0.00529	CcSEcCtD
Methotrexate—AOX1—adrenal gland—hypothyroidism	0.000303	0.00355	CbGeAlD
Methotrexate—MTHFR—cerebellum—hypothyroidism	0.000303	0.00355	CbGeAlD
Methotrexate—SLC16A1—female gonad—hypothyroidism	0.0003	0.00351	CbGeAlD
Methotrexate—TYMS—testis—hypothyroidism	0.000299	0.0035	CbGeAlD
Methotrexate—Asthenia—Levothyroxine—hypothyroidism	0.000298	0.00519	CcSEcCtD
Methotrexate—Asthenia—Dextrothyroxine—hypothyroidism	0.000298	0.00519	CcSEcCtD
Methotrexate—SLCO3A1—cerebellum—hypothyroidism	0.000298	0.00349	CbGeAlD
Methotrexate—ABCC3—adrenal gland—hypothyroidism	0.000297	0.00347	CbGeAlD
Methotrexate—ABCC3—blood—hypothyroidism	0.000296	0.00347	CbGeAlD
Methotrexate—DHFR—testis—hypothyroidism	0.000296	0.00347	CbGeAlD
Methotrexate—Hyperhidrosis—Liotrix—hypothyroidism	0.000295	0.00515	CcSEcCtD
Methotrexate—ABCC10—adrenal gland—hypothyroidism	0.000295	0.00346	CbGeAlD
Methotrexate—ABCC10—blood—hypothyroidism	0.000295	0.00346	CbGeAlD
Methotrexate—Pruritus—Levothyroxine—hypothyroidism	0.000294	0.00512	CcSEcCtD
Methotrexate—Pruritus—Dextrothyroxine—hypothyroidism	0.000294	0.00512	CcSEcCtD
Methotrexate—AOX1—thyroid gland—hypothyroidism	0.000293	0.00343	CbGeAlD
Methotrexate—Anorexia—Liotrix—hypothyroidism	0.000291	0.00508	CcSEcCtD
Methotrexate—ABCC1—adrenal cortex—hypothyroidism	0.000289	0.00339	CbGeAlD
Methotrexate—ABCC3—thyroid gland—hypothyroidism	0.000286	0.00335	CbGeAlD
Methotrexate—Hypotension—Liotrix—hypothyroidism	0.000285	0.00498	CcSEcCtD
Methotrexate—ABCC10—thyroid gland—hypothyroidism	0.000285	0.00334	CbGeAlD
Methotrexate—PGD—testis—hypothyroidism	0.000285	0.00333	CbGeAlD
Methotrexate—Diarrhoea—Levothyroxine—hypothyroidism	0.000284	0.00495	CcSEcCtD
Methotrexate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000284	0.00495	CcSEcCtD
Methotrexate—AOX1—female gonad—hypothyroidism	0.000283	0.00331	CbGeAlD
Methotrexate—TYMS—liver—hypothyroidism	0.000283	0.00331	CbGeAlD
Methotrexate—DHFR—liver—hypothyroidism	0.00028	0.00328	CbGeAlD
Methotrexate—ABCC1—heart—hypothyroidism	0.00028	0.00328	CbGeAlD
Methotrexate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000278	0.00485	CcSEcCtD
Methotrexate—ABCC3—female gonad—hypothyroidism	0.000277	0.00324	CbGeAlD
Methotrexate—TYMS—cerebellum—hypothyroidism	0.000276	0.00324	CbGeAlD
Methotrexate—Insomnia—Liotrix—hypothyroidism	0.000276	0.00482	CcSEcCtD
Methotrexate—ABCC10—female gonad—hypothyroidism	0.000275	0.00322	CbGeAlD
Methotrexate—Paraesthesia—Liotrix—hypothyroidism	0.000274	0.00478	CcSEcCtD
Methotrexate—DHFR—cerebellum—hypothyroidism	0.000273	0.0032	CbGeAlD
Methotrexate—Dyspnoea—Liotrix—hypothyroidism	0.000272	0.00475	CcSEcCtD
Methotrexate—PGD—liver—hypothyroidism	0.000269	0.00315	CbGeAlD
Methotrexate—SLC16A1—testis—hypothyroidism	0.000266	0.00311	CbGeAlD
Methotrexate—Decreased appetite—Liotrix—hypothyroidism	0.000265	0.00463	CcSEcCtD
Methotrexate—Vomiting—Levothyroxine—hypothyroidism	0.000264	0.0046	CcSEcCtD
Methotrexate—Vomiting—Dextrothyroxine—hypothyroidism	0.000264	0.0046	CcSEcCtD
Methotrexate—Fatigue—Liotrix—hypothyroidism	0.000263	0.00459	CcSEcCtD
Methotrexate—PGD—cerebellum—hypothyroidism	0.000263	0.00308	CbGeAlD
Methotrexate—Rash—Dextrothyroxine—hypothyroidism	0.000262	0.00456	CcSEcCtD
Methotrexate—Rash—Levothyroxine—hypothyroidism	0.000262	0.00456	CcSEcCtD
Methotrexate—Dermatitis—Dextrothyroxine—hypothyroidism	0.000261	0.00456	CcSEcCtD
Methotrexate—Dermatitis—Levothyroxine—hypothyroidism	0.000261	0.00456	CcSEcCtD
Methotrexate—Headache—Levothyroxine—hypothyroidism	0.00026	0.00453	CcSEcCtD
Methotrexate—Headache—Dextrothyroxine—hypothyroidism	0.00026	0.00453	CcSEcCtD
Methotrexate—ALB—adrenal gland—hypothyroidism	0.000253	0.00296	CbGeAlD
Methotrexate—Feeling abnormal—Liotrix—hypothyroidism	0.000252	0.00439	CcSEcCtD
Methotrexate—SLC16A1—liver—hypothyroidism	0.000251	0.00294	CbGeAlD
Methotrexate—AOX1—testis—hypothyroidism	0.000251	0.00294	CbGeAlD
Methotrexate—Gastrointestinal pain—Liotrix—hypothyroidism	0.00025	0.00435	CcSEcCtD
Methotrexate—Nausea—Levothyroxine—hypothyroidism	0.000247	0.0043	CcSEcCtD
Methotrexate—Nausea—Dextrothyroxine—hypothyroidism	0.000247	0.0043	CcSEcCtD
Methotrexate—SLC16A1—cerebellum—hypothyroidism	0.000245	0.00288	CbGeAlD
Methotrexate—ABCC3—testis—hypothyroidism	0.000245	0.00287	CbGeAlD
Methotrexate—ABCC4—adrenal gland—hypothyroidism	0.000245	0.00287	CbGeAlD
Methotrexate—ABCC4—blood—hypothyroidism	0.000245	0.00287	CbGeAlD
Methotrexate—SLCO1B1—liver—hypothyroidism	0.000244	0.00286	CbGeAlD
Methotrexate—ABCC10—testis—hypothyroidism	0.000244	0.00286	CbGeAlD
Methotrexate—SLC22A8—blood—hypothyroidism	0.000243	0.00284	CbGeAlD
Methotrexate—Urticaria—Liotrix—hypothyroidism	0.000243	0.00423	CcSEcCtD
Methotrexate—Body temperature increased—Liotrix—hypothyroidism	0.000241	0.00421	CcSEcCtD
Methotrexate—Abdominal pain—Liotrix—hypothyroidism	0.000241	0.00421	CcSEcCtD
Methotrexate—ABCG2—adrenal cortex—hypothyroidism	0.000239	0.0028	CbGeAlD
Methotrexate—AOX1—liver—hypothyroidism	0.000237	0.00278	CbGeAlD
Methotrexate—ABCC2—adrenal gland—hypothyroidism	0.000237	0.00278	CbGeAlD
Methotrexate—ABCC2—blood—hypothyroidism	0.000237	0.00278	CbGeAlD
Methotrexate—ABCC4—thyroid gland—hypothyroidism	0.000236	0.00277	CbGeAlD
Methotrexate—ABCC1—pituitary gland—hypothyroidism	0.000234	0.00274	CbGeAlD
Methotrexate—ABCC3—liver—hypothyroidism	0.000232	0.00272	CbGeAlD
Methotrexate—AOX1—cerebellum—hypothyroidism	0.000232	0.00271	CbGeAlD
Methotrexate—ABCG2—heart—hypothyroidism	0.000232	0.00271	CbGeAlD
Methotrexate—ABCC10—liver—hypothyroidism	0.000231	0.0027	CbGeAlD
Methotrexate—ABCC4—female gonad—hypothyroidism	0.000228	0.00267	CbGeAlD
Methotrexate—ABCC10—cerebellum—hypothyroidism	0.000225	0.00264	CbGeAlD
Methotrexate—Hypersensitivity—Liotrix—hypothyroidism	0.000225	0.00392	CcSEcCtD
Methotrexate—Asthenia—Liotrix—hypothyroidism	0.000219	0.00382	CcSEcCtD
Methotrexate—Pruritus—Liotrix—hypothyroidism	0.000216	0.00377	CcSEcCtD
Methotrexate—SLCO1A2—testis—hypothyroidism	0.00021	0.00246	CbGeAlD
Methotrexate—ALB—testis—hypothyroidism	0.000209	0.00245	CbGeAlD
Methotrexate—Diarrhoea—Liotrix—hypothyroidism	0.000209	0.00364	CcSEcCtD
Methotrexate—ABCC1—adrenal gland—hypothyroidism	0.000209	0.00245	CbGeAlD
Methotrexate—ABCC1—blood—hypothyroidism	0.000209	0.00245	CbGeAlD
Methotrexate—ABCC4—testis—hypothyroidism	0.000202	0.00237	CbGeAlD
Methotrexate—Dizziness—Liotrix—hypothyroidism	0.000202	0.00352	CcSEcCtD
Methotrexate—ABCC1—thyroid gland—hypothyroidism	0.000201	0.00236	CbGeAlD
Methotrexate—SLCO1A2—liver—hypothyroidism	0.000199	0.00233	CbGeAlD
Methotrexate—ALB—liver—hypothyroidism	0.000198	0.00232	CbGeAlD
Methotrexate—ABCC2—testis—hypothyroidism	0.000196	0.0023	CbGeAlD
Methotrexate—ABCC1—female gonad—hypothyroidism	0.000195	0.00228	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—hypothyroidism	0.000194	0.00228	CbGeAlD
Methotrexate—Vomiting—Liotrix—hypothyroidism	0.000194	0.00339	CcSEcCtD
Methotrexate—ABCG2—pituitary gland—hypothyroidism	0.000193	0.00227	CbGeAlD
Methotrexate—Rash—Liotrix—hypothyroidism	0.000192	0.00336	CcSEcCtD
Methotrexate—Dermatitis—Liotrix—hypothyroidism	0.000192	0.00335	CcSEcCtD
Methotrexate—ABCC4—liver—hypothyroidism	0.000191	0.00224	CbGeAlD
Methotrexate—Headache—Liotrix—hypothyroidism	0.000191	0.00334	CcSEcCtD
Methotrexate—ABCC2—liver—hypothyroidism	0.000185	0.00217	CbGeAlD
Methotrexate—Nausea—Liotrix—hypothyroidism	0.000181	0.00316	CcSEcCtD
Methotrexate—ABCG2—adrenal gland—hypothyroidism	0.000173	0.00202	CbGeAlD
Methotrexate—ABCG2—blood—hypothyroidism	0.000173	0.00202	CbGeAlD
Methotrexate—ABCC1—testis—hypothyroidism	0.000173	0.00202	CbGeAlD
Methotrexate—ABCG2—thyroid gland—hypothyroidism	0.000167	0.00195	CbGeAlD
Methotrexate—ABCC1—liver—hypothyroidism	0.000163	0.00191	CbGeAlD
Methotrexate—ABCG2—female gonad—hypothyroidism	0.000161	0.00189	CbGeAlD
Methotrexate—ABCC1—cerebellum—hypothyroidism	0.000159	0.00187	CbGeAlD
Methotrexate—ABCG2—testis—hypothyroidism	0.000143	0.00167	CbGeAlD
Methotrexate—ABCG2—liver—hypothyroidism	0.000135	0.00158	CbGeAlD
Methotrexate—ABCG2—cerebellum—hypothyroidism	0.000132	0.00155	CbGeAlD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000121	0.00333	CbGpPWpGaD
Methotrexate—ABCB1—adrenal cortex—hypothyroidism	0.000118	0.00138	CbGeAlD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000116	0.00321	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TPO—hypothyroidism	0.000115	0.00318	CbGpPWpGaD
Methotrexate—ABCB1—heart—hypothyroidism	0.000114	0.00134	CbGeAlD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000114	0.00314	CbGpPWpGaD
Methotrexate—ABCC3—NRF2 pathway—SLC5A5—hypothyroidism	0.000113	0.00311	CbGpPWpGaD
Methotrexate—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000111	0.00306	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000111	0.00306	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00011	0.00303	CbGpPWpGaD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00011	0.00302	CbGpPWpGaD
Methotrexate—ABCB1—cardiovascular system—hypothyroidism	0.000108	0.00126	CbGeAlD
Methotrexate—ABCC4—NRF2 pathway—SLC5A5—hypothyroidism	0.000106	0.00293	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000106	0.00291	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.0001	0.00276	CbGpPWpGaD
Methotrexate—ABCB1—gonad—hypothyroidism	9.78e-05	0.00115	CbGeAlD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.64e-05	0.00266	CbGpPWpGaD
Methotrexate—ABCB1—pituitary gland—hypothyroidism	9.54e-05	0.00112	CbGeAlD
Methotrexate—MTHFR—Metabolism—IYD—hypothyroidism	9.53e-05	0.00263	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.46e-05	0.00261	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.34e-05	0.00257	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.34e-05	0.00257	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—IYD—hypothyroidism	9.31e-05	0.00256	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.15e-05	0.00252	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.05e-05	0.00249	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.98e-05	0.00247	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	8.95e-05	0.00247	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.87e-05	0.00245	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.85e-05	0.00244	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—TSHB—hypothyroidism	8.82e-05	0.00243	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.75e-05	0.00241	CbGpPWpGaD
Methotrexate—ABCC4—Platelet degranulation—IGF1—hypothyroidism	8.65e-05	0.00238	CbGpPWpGaD
Methotrexate—ABCB1—adrenal gland—hypothyroidism	8.52e-05	0.000998	CbGeAlD
Methotrexate—ABCB1—blood—hypothyroidism	8.52e-05	0.000998	CbGeAlD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.51e-05	0.00234	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—IYD—hypothyroidism	8.47e-05	0.00233	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.45e-05	0.00233	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—AVP—hypothyroidism	8.32e-05	0.00229	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.31e-05	0.00229	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.31e-05	0.00229	CbGpPWpGaD
Methotrexate—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	8.24e-05	0.00227	CbGpPWpGaD
Methotrexate—ABCB1—thyroid gland—hypothyroidism	8.22e-05	0.000963	CbGeAlD
Methotrexate—MTHFR—Metabolism—ATP5O—hypothyroidism	8.1e-05	0.00223	CbGpPWpGaD
Methotrexate—ABCB1—female gonad—hypothyroidism	7.94e-05	0.000931	CbGeAlD
Methotrexate—AOX1—Metabolism—ATP5O—hypothyroidism	7.91e-05	0.00218	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	7.89e-05	0.00217	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.88e-05	0.00217	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PIK3C2A—hypothyroidism	7.86e-05	0.00217	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—IYD—hypothyroidism	7.71e-05	0.00212	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TPO—hypothyroidism	7.62e-05	0.0021	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	7.58e-05	0.00209	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—TSHB—hypothyroidism	7.5e-05	0.00207	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—TSHB—hypothyroidism	7.5e-05	0.00207	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.5e-05	0.00207	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TPO—hypothyroidism	7.44e-05	0.00205	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.41e-05	0.00204	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—IYD—hypothyroidism	7.39e-05	0.00204	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—AVP—hypothyroidism	7.35e-05	0.00203	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.35e-05	0.00203	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—AVP—hypothyroidism	7.35e-05	0.00203	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.21e-05	0.00199	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ATP5O—hypothyroidism	7.2e-05	0.00198	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.17e-05	0.00198	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.09e-05	0.00195	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.08e-05	0.00195	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.07e-05	0.00195	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.05e-05	0.00194	CbGpPWpGaD
Methotrexate—ABCB1—testis—hypothyroidism	7.05e-05	0.000826	CbGeAlD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.98e-05	0.00192	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.97e-05	0.00192	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PRL—hypothyroidism	6.97e-05	0.00192	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—IYD—hypothyroidism	6.78e-05	0.00187	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TPO—hypothyroidism	6.77e-05	0.00186	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.74e-05	0.00186	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PIK3C2A—hypothyroidism	6.69e-05	0.00184	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PIK3C2A—hypothyroidism	6.69e-05	0.00184	CbGpPWpGaD
Methotrexate—ABCB1—liver—hypothyroidism	6.66e-05	0.000781	CbGeAlD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.65e-05	0.00183	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—SLC5A5—hypothyroidism	6.6e-05	0.00182	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ATP5O—hypothyroidism	6.56e-05	0.00181	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.54e-05	0.0018	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.53e-05	0.0018	CbGpPWpGaD
Methotrexate—ABCB1—cerebellum—hypothyroidism	6.51e-05	0.000763	CbGeAlD
Methotrexate—TYMS—Metabolism—ATP5O—hypothyroidism	6.28e-05	0.00173	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	6.28e-05	0.00173	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—SH2B3—hypothyroidism	6.27e-05	0.00173	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.24e-05	0.00172	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	6.23e-05	0.00172	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.21e-05	0.00171	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.2e-05	0.00171	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TPO—hypothyroidism	6.16e-05	0.0017	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.14e-05	0.00169	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—IYD—hypothyroidism	6.11e-05	0.00168	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.95e-05	0.00164	CbGpPWpGaD
Methotrexate—FPGS—Disease—PRL—hypothyroidism	5.92e-05	0.00163	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—TPO—hypothyroidism	5.91e-05	0.00163	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.88e-05	0.00162	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—TSHB—hypothyroidism	5.84e-05	0.00161	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.83e-05	0.00161	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ATP5O—hypothyroidism	5.76e-05	0.00159	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—SLC5A5—hypothyroidism	5.62e-05	0.00155	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SLC5A5—hypothyroidism	5.62e-05	0.00155	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.58e-05	0.00154	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.57e-05	0.00154	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.54e-05	0.00153	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.5e-05	0.00151	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TPO—hypothyroidism	5.42e-05	0.00149	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TSHB—hypothyroidism	5.34e-05	0.00147	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—IYD—hypothyroidism	5.32e-05	0.00147	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.3e-05	0.00146	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PIK3C2A—hypothyroidism	5.21e-05	0.00144	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ATP5O—hypothyroidism	5.2e-05	0.00143	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.17e-05	0.00142	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.02e-05	0.00138	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TPO—hypothyroidism	4.89e-05	0.00135	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.88e-05	0.00134	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—IYD—hypothyroidism	4.79e-05	0.00132	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PIK3C2A—hypothyroidism	4.76e-05	0.00131	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—SH2B3—hypothyroidism	4.68e-05	0.00129	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.65e-05	0.00128	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PRL—hypothyroidism	4.61e-05	0.00127	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.59e-05	0.00126	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.56e-05	0.00126	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—IYD—hypothyroidism	4.55e-05	0.00125	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.53e-05	0.00125	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ATP5O—hypothyroidism	4.53e-05	0.00125	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SLC5A5—hypothyroidism	4.37e-05	0.00121	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—VAV3—hypothyroidism	4.31e-05	0.00119	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TPO—hypothyroidism	4.26e-05	0.00117	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.22e-05	0.00116	CbGpPWpGaD
Methotrexate—PGD—Disease—PRL—hypothyroidism	4.22e-05	0.00116	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—IYD—hypothyroidism	4.22e-05	0.00116	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.17e-05	0.00115	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ATP5O—hypothyroidism	4.07e-05	0.00112	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.01e-05	0.0011	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SLC5A5—hypothyroidism	4e-05	0.0011	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.94e-05	0.00109	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—IGF1—hypothyroidism	3.91e-05	0.00108	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ATP5O—hypothyroidism	3.87e-05	0.00107	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.85e-05	0.00106	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.84e-05	0.00106	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TPO—hypothyroidism	3.83e-05	0.00106	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	3.73e-05	0.00103	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—AVP—hypothyroidism	3.66e-05	0.00101	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TPO—hypothyroidism	3.64e-05	0.001	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.62e-05	0.000997	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.59e-05	0.000989	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ATP5O—hypothyroidism	3.58e-05	0.000988	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.55e-05	0.000978	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.55e-05	0.000977	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TSHB—hypothyroidism	3.53e-05	0.000972	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—POMC—hypothyroidism	3.46e-05	0.000952	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TSHB—hypothyroidism	3.44e-05	0.000949	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.4e-05	0.000937	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.37e-05	0.000929	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.37e-05	0.000929	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TPO—hypothyroidism	3.37e-05	0.000929	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—AVP—hypothyroidism	3.32e-05	0.000916	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VAV3—hypothyroidism	3.21e-05	0.000885	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	3.19e-05	0.000879	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	3.16e-05	0.00087	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.15e-05	0.000868	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PIK3C2A—hypothyroidism	3.14e-05	0.000866	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TSHB—hypothyroidism	3.13e-05	0.000863	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PIK3C2A—hypothyroidism	3.07e-05	0.000846	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	3.03e-05	0.000834	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.96e-05	0.000816	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—POMC—hypothyroidism	2.94e-05	0.000809	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—POMC—hypothyroidism	2.94e-05	0.000809	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.87e-05	0.00079	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TSHB—hypothyroidism	2.85e-05	0.000786	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—AVP—hypothyroidism	2.85e-05	0.000785	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.83e-05	0.000781	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	2.82e-05	0.000777	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.8e-05	0.00077	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PIK3C2A—hypothyroidism	2.79e-05	0.000769	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—AVP—hypothyroidism	2.79e-05	0.000769	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PRL—hypothyroidism	2.78e-05	0.000767	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—TSHB—hypothyroidism	2.73e-05	0.000753	CbGpPWpGaD
Methotrexate—AOX1—Disease—PRL—hypothyroidism	2.72e-05	0.000749	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.69e-05	0.000742	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—AVP—hypothyroidism	2.68e-05	0.000738	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IGF1—hypothyroidism	2.65e-05	0.000731	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC5A5—hypothyroidism	2.64e-05	0.000727	CbGpPWpGaD
Methotrexate—ALB—Metabolism—IYD—hypothyroidism	2.6e-05	0.000717	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC5A5—hypothyroidism	2.58e-05	0.00071	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PIK3C2A—hypothyroidism	2.54e-05	0.000701	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TSHB—hypothyroidism	2.51e-05	0.000691	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.49e-05	0.000687	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.48e-05	0.000683	CbGpPWpGaD
Methotrexate—DHFR—Disease—PRL—hypothyroidism	2.47e-05	0.000682	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PIK3C2A—hypothyroidism	2.44e-05	0.000671	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	2.38e-05	0.000657	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC5A5—hypothyroidism	2.35e-05	0.000646	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	2.33e-05	0.000642	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—POMC—hypothyroidism	2.29e-05	0.000631	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—IYD—hypothyroidism	2.28e-05	0.000628	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TSHB—hypothyroidism	2.26e-05	0.000624	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.26e-05	0.000622	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	2.24e-05	0.000616	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.23e-05	0.000615	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ATP5O—hypothyroidism	2.21e-05	0.000609	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.21e-05	0.000608	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC5A5—hypothyroidism	2.14e-05	0.000589	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.12e-05	0.000584	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SH2B3—hypothyroidism	2.12e-05	0.000583	CbGpPWpGaD
Methotrexate—PGD—Metabolism—POMC—hypothyroidism	2.09e-05	0.000577	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TPO—hypothyroidism	2.08e-05	0.000573	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC5A5—hypothyroidism	2.05e-05	0.000564	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3C2A—hypothyroidism	2.02e-05	0.000556	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.99e-05	0.000548	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IGF1—hypothyroidism	1.98e-05	0.000545	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TSHB—hypothyroidism	1.97e-05	0.000543	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.96e-05	0.000541	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ATP5O—hypothyroidism	1.94e-05	0.000534	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.93e-05	0.000531	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	1.88e-05	0.000517	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TPO—hypothyroidism	1.82e-05	0.000502	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TSHB—hypothyroidism	1.77e-05	0.000489	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	1.76e-05	0.000484	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.74e-05	0.000478	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.73e-05	0.000478	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.71e-05	0.000471	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC5A5—hypothyroidism	1.69e-05	0.000467	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.69e-05	0.000464	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3C2A—hypothyroidism	1.58e-05	0.000435	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TSHB—hypothyroidism	1.56e-05	0.00043	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.56e-05	0.00043	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.54e-05	0.000424	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.5e-05	0.000414	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.48e-05	0.000408	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	1.48e-05	0.000406	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VAV3—hypothyroidism	1.45e-05	0.0004	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PRL—hypothyroidism	1.4e-05	0.000386	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3C2A—hypothyroidism	1.39e-05	0.000383	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—POMC—hypothyroidism	1.38e-05	0.000381	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—POMC—hypothyroidism	1.35e-05	0.000372	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.35e-05	0.000372	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC5A5—hypothyroidism	1.33e-05	0.000366	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.26e-05	0.000348	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—POMC—hypothyroidism	1.23e-05	0.000338	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	1.21e-05	0.000334	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC5A5—hypothyroidism	1.17e-05	0.000322	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—POMC—hypothyroidism	1.12e-05	0.000308	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—POMC—hypothyroidism	1.07e-05	0.000295	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.06e-05	0.000292	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—POMC—hypothyroidism	9.82e-06	0.000271	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TSHB—hypothyroidism	9.63e-06	0.000265	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—hypothyroidism	8.95e-06	0.000247	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—POMC—hypothyroidism	8.86e-06	0.000244	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3C2A—hypothyroidism	8.58e-06	0.000236	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.47e-06	0.000233	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TSHB—hypothyroidism	8.44e-06	0.000232	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—hypothyroidism	7.72e-06	0.000213	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3C2A—hypothyroidism	7.52e-06	0.000207	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC5A5—hypothyroidism	7.21e-06	0.000199	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—hypothyroidism	6.95e-06	0.000191	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—hypothyroidism	6.6e-06	0.000182	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC5A5—hypothyroidism	6.32e-06	0.000174	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—hypothyroidism	6.11e-06	0.000168	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—hypothyroidism	3.77e-06	0.000104	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—hypothyroidism	3.3e-06	9.1e-05	CbGpPWpGaD
